What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His scientific interests lie mostly in Midkine, Molecular biology, Cell biology, Growth factor and Pathology.
He has included themes like Cancer research, Pleiotrophin, Carcinogenesis, Transfection and Carcinoma in his Midkine study.
His Molecular biology research includes themes of Cellular differentiation, Embryo, Embryogenesis, Complementary DNA and Retinoic acid.
The various areas that Kenji Kadomatsu examines in his Cell biology study include Syndecan 1, Integrin, Basigin and Central nervous system.
His Growth factor research incorporates elements of Apoptosis, Endocrinology, Cell growth and Wilms' tumor.
His studies examine the connections between Pathology and genetics, as well as such issues in Gene expression, with regards to Epithelioma.
His most cited work include:
- cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. (445 citations)
- A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics (373 citations)
- Minocycline selectively inhibits M1 polarization of microglia (371 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Midkine, Molecular biology, Internal medicine, Cell biology and Cancer research.
His Midkine research focuses on Pathology and how it relates to Microglia.
His research integrates issues of Biochemistry, Gene expression, Gene, Transfection and Antibody in his study of Molecular biology.
His studies in Internal medicine integrate themes in fields like Endocrinology and Cardiology.
The Cell biology study combines topics in areas such as Chondroitin sulfate, Basigin, Central nervous system and Immunology.
Kenji Kadomatsu interconnects Carcinogenesis and Neuroblastoma in the investigation of issues within Cancer research.
He most often published in these fields:
- Midkine (38.79%)
- Molecular biology (20.32%)
- Internal medicine (20.58%)
What were the highlights of his more recent work (between 2014-2021)?
- Cancer research (17.94%)
- Cell biology (18.21%)
- Neuroblastoma (7.39%)
In recent papers he was focusing on the following fields of study:
Kenji Kadomatsu focuses on Cancer research, Cell biology, Neuroblastoma, Internal medicine and Midkine.
In his research on the topic of Cancer research, Antibody and In vitro is strongly related with Molecular biology.
His work carried out in the field of Cell biology brings together such families of science as Embryonic stem cell, Chondroitin sulfate and Spinal cord.
His Neuroblastoma research is multidisciplinary, relying on both DNA damage, Cell growth, Gene knockdown, Carcinogenesis and Neural crest.
His work is dedicated to discovering how Internal medicine, Endocrinology are connected with Knockout mouse, Cellular differentiation and Basigin and other disciplines.
Midkine is a subfield of Growth factor that Kenji Kadomatsu explores.
Between 2014 and 2021, his most popular works were:
- Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma (53 citations)
- Origin and initiation mechanisms of neuroblastoma (39 citations)
- Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice (34 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Cancer research, Neuroblastoma, Cell biology, Pathology and Molecular biology are his primary areas of study.
His study in Cell biology is interdisciplinary in nature, drawing from both Cell culture and Chondroitin sulfate.
He combines subjects such as Lipopolysaccharide, Immunology, Microglia and Glycan with his study of Pathology.
His Molecular biology research integrates issues from Combination chemotherapy, In vitro, Antigen, B cell and Activator.
His Cell type research is multidisciplinary, incorporating elements of Internal medicine and Endocrinology.
His Epidermal growth factor receptor and Midkine study in the realm of Internal medicine connects with subjects such as Docosahexaenoic acid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
